At the 2022 edition of the Pharma Manufacturing World Summit series held March 29-30 in Boston, MA, we spoke with Jack Garvey, the CEO of Compliance Architects. Jack is a long-time supporter of Executive Platforms' pharmaceutical manufacturing series who has co-chaired many of our events on content related to Quality and Risk, and in this interview we explored in detail three top-of-mind challenges and opportunities the industry is facing today: Talent and the future of Talent; the FDA's return to pre-pandemic practices, and developing best practices as part of the growing necessity of working with CMOs and CDMOs.

--

Jack Garvey is the Founder and Chief Executive Officer of Compliance Architects, a leading consulting and advisory firm specializing in innovative quality and compliance solutions for FDA-regulated manufacturers. Jack possesses over 30 years of hands-on technical, operational, quality, regulatory and legal experience at top-performing life science companies including Johnson & Johnson, C.R. Bard, Ciba-Geigy, BASF Corporation and Ayerst Laboratories. As both a chemical engineer and practicing attorney, Jack possesses the legal, regulatory, quality and compliance expertise that allows him to excel at the complex interplay of science, law and business.

--

Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes. Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.

www.compliancearchitects.com